Cite
HARVARD Citation
Leung, M. et al. (2020). Blood‐based circulating tumor DNA mutations as a diagnostic and prognostic biomarker for lung cancer. Cancer. 126 (8), pp. 1804-1809. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Leung, M. et al. (2020). Blood‐based circulating tumor DNA mutations as a diagnostic and prognostic biomarker for lung cancer. Cancer. 126 (8), pp. 1804-1809. [Online].